Modification of electroplax excitability by veratridine.
D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D002118:Calcium / Q000494:pharmacology; D002217:Carbachol / Q000494:pharmacology; D004557:Electric Organ / Q000187:drug effects / Q000502:physiology*; D005071:Evoked Potentials / Q000187:drug effects; D006863:Hydrogen-Ion Concentration; D008564:Membrane Potentials / Q000187:drug effects*; D009994:Osmolar Concentration; D010276:Parasympatholytics; D011188:Potassium / Q000494:pharmacology; D012964:Sodium / Q000494:pharmacology; D013696:Temperature; D013748:Tetracaine / Q000494:pharmacology; D013779:Tetrodotoxin / Q000494:pharmacology; D013997:Time Factors; D014702:Veratrine / Q000494:pharmacology*
D010276:Parasympatholytics; D013748:Tetracaine; D013779:Tetrodotoxin; D002217:Carbachol; D012964:Sodium; D014702:Veratrine; D011188:Potassium; D002118:Calcium